Animal health industry comprises various products and services used for maintaining well-being of companion animals and food producing animals. Animal health products mainly include parasiticides, antimicrobials & antibiotic ....see more
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
The global dairy herd management market, valued at US$4.16 billion in 2024, stood at US$4.99 billion in 2025 and is projected to advance at a resilient CAGR of 8.6% from 2025 to 2032, culminating in a forecasted valuation of US$8.88 billion by the end of the period. Key factors fueling market growth include increasing demand for high-quality dairy products, growing herd size, and rising adoption of automated milking systems.
The global pet insurance market, valued at US$12.51 billion in 2024, stood at US$14.35 billion in 2025 and is projected to advance at a resilient CAGR of 15.7% from 2025 to 2030, culminating in a forecasted valuation of US$29.80 billion by the end of the period. This growth is mainly driven by changing consumer preferences, increasing veterinary care costs, and the growing adoption of digital technologies throughout the insurance industry.
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
The global veterinary diagnostics market, valued at US$3.42 billion in 2024, stood at US$3.68 billion in 2025 and is projected to advance at a resilient CAGR of 7.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.36 billion by the end of the period.
Global veterinary dermatology market valued at $18.59B in 2024, reached $20.11B in 2025, and is projected to grow at a robust 8.5% CAGR, hitting $ 30.31B by 2030. The major factors that are driving the market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure.
The global veterinary ultrasound market, valued at US$360.6 million in 2023, stood at US$384.6 million in 2024 and is projected to advance at a resilient CAGR of 7.0 % from 2024 to 2029, culminating in a forecasted valuation of US$539.4 million by the end of the period. The veterinary ultrasound market is driven by the growing demand for veterinary technicians, advancements in technology, and rising pet healthcare expenditure.
The global udder health market, valued at US$1.13 billion in 2023, stood at US$1.18 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$1.58 billion by the end of the period. The growth in the udder health market can be attributed to the factors, including increasing investments, funds, and grants by governments and other organizations, rising number of veterinarians in the developing countries.
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
The global veterinary vaccines market, valued at US$8.93 billion in 2023, stood at US$9.39 billion in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$13.33 billion by the end of the period.. Growing awareness of animal health, along with the rising pet population and ownership, is driving the adoption of veterinary vaccines. Government efforts to improve animal health and the increasing popularity of pet insurance are also contributing to this trend.
The global companion animal diagnostics market, valued at US$2.75 billion in 2023, stood at US$2.99 billion in 2024 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2029, culminating in a forecasted valuation of US$4.55 billion by the end of the period. The growing demand for rapid tests and portable instruments for point-of-care (POC) services is offering growth opportunities for players in the companion animal diagnostics market.
The global animal genetics market, valued at US$2.76 billion in 2023, stood at US$2.97 billion in 2024 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2029, culminating in a forecasted valuation of US$4.19 billion by the end of the period. Market growth is largely driven by factors such as the increasing consumption of animal-derived protein, growing global population & rapid urbanization, growing customer awareness, increasing demand for companion animals, focus on superior breeds, and an emphasis on genetic services to prevent genetic diseases & business loss.
The global cattle & porcine/swine reproductive diseases market, valued at US$726.9 million in 2023, stood at US$758.2 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$975.8 million by the end of the period. Increasing investments, funding, and grants from various governments and organizations to improve animal health, along with a growing number of veterinarians in developing nations, are enhancing the treatment of diseases.
The global veterinary surgical procedures market, valued at US$45.4 billion in 2023, stood at US$48.3 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$67.8 billion by the end of the period. Development of new surgical instruments, robotics, and imaging technologies like 3D printing and VR training for vets, improves efficiency and success rates of procedures which is expected to drive the growth of the market.
The global veterinary ophthalmology equipment market, valued at US$451 million in 2023, stood at US$485 million in 2024 and is projected to advance at a resilient CAGR of 7.5% from 2024 to 2029, culminating in a forecasted valuation of US$697 million by the end of the period. The veterinary ophthalmology equipment market is driven by the growing demand for specialized eye care for pets, advancements in technology, and rising pet healthcare expenditure.
The global veterinary reference laboratory market, valued at US$4.0B in 2022, is forecasted to grow at a 11.2% CAGR, reaching US$4.6B by 2024 and US$7.8B by 2029. The veterinary reference laboratory market is experiencing significant growth due to increase in pet ownership, greater investment in animal healthcare, and an expanding focus on preventive measures.
The global animal wound care market, valued at US$1.2 billion in 2023, stood at US$1.3 billion in 2024 and is projected to advance at a resilient CAGR of 7.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.0 billion by the end of the period. Growth in APAC market can be attributed to increasing investments in veterinary infrastructure, fostering the adoption of advanced veterinary wound care products.
The global veterinary imaging market, valued at US$1.8 billion in 2022, stood at US$1.9 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2029, culminating in a forecasted valuation of US$2.9 billion by the end of the period. Rising pet ownership, increased pet insurance penetration, and growing awareness of animal health are driving demand for accurate diagnoses.
The global veterinary equipment and supplies market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.1% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. The primary factors driving growth for the veterinary equipment supplies market during the projected period are advancements in veterinary technology, an increase in the population of pets and their owners, increasing demand for livestock veterinary products, rise in the need for pet insurance, an increase in the expense of animal health care, and an increase in the prevalence of diseases in animals.
The global veterinary electrosurgery market in terms of revenue was estimated to be worth $85 million in 2023 and is poised to reach $120 million by 2028, growing at a CAGR of 7.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global veterinary telemedicine market, valued at US$457 million in 2022, stood at US$530 million in 2023 and is projected to advance at a resilient CAGR of 18.3% from 2023 to 2028, culminating in a forecasted valuation of US$1,230 million by the end of the period. Growth in this market is largely driven by the increasing adoption of Internet of Things (IoT) and Artificial Intelligence (AI) technologies both pet owners and the veterinary industry has significantly influenced the development and effectiveness of veterinary telemedicine.
The global veterinary API market, valued at US$8.0 billion in 2022, stood at US$8.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$11.9 billion by the end of the period. The veterinary active pharmaceutical ingredient (API) market is growing due to various factors, including the increased occurrence of transboundary and zoonotic diseases, a rise in the global animal population and pet ownership, and the implementation of improved disease control and prevention measures.
The global animal parasiticides market in terms of revenue was estimated to be worth $10.6 billion in 2022 and is poised to reach $14.1 billion by 2027, growing at a CAGR of 5.8% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
Veterinary pain management market growth is primed to transition from $1.8 billion in 2022 to $2.5 billion by 2027, showcasing a strong CAGR of 6.7%. Factors such as growth in companion animal adoption, the increasing number of veterinary practitioners and their rising income levels in developed economies, increasing consumption of meat & milk, the growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of this market.
The size of animal growth promoters and performance enhancers market industry is projected to grow from USD 16.2 billion in 2021 and to reach USD 21.4 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global Asia Pacific Animal Health Market in terms of revenue was estimated to be worth $15.6 billion in 2020 and is poised to reach $22.1 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The Veterinary Monitoring Equipment Market is expected to grow from USD 326 million in 2019 to USD 570 million by 2025, at a CAGR of 9.8% during the forecast period. Prominent players in the veterinary monitoring equipment market include Smiths Group plc. (UK), DRE Veterinary (US), Digicare Biomedical Technology (US), Midmark Corporation (US), Medtronic plc. (Ireland), Bionet America, Inc. (Korea), SonoScape Medical Corporation (China), Hallowell EMC (US), MinXray, Inc. (US), Hallmarq Veterinary Imaging Ltd. (UK), Esaote S.p.A (Italy), Agfa-Gevaert N.V. (Belgium), Nonin Medical, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Covetrus, Inc. (US), Vetland Medical Sales & Services LLC (US), Masimo Corporation (US), Burtons Medical Equipment Ltd. (UK), Vetronic Services (UK), and IMV Technologies (France).
The global veterinary rapid tests market is projected to reach USD 854 million by 2024 from USD 573 million in 2019, at a CAGR of 8.3%. Factors contributing to the growth of this market include the increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases. The prominent players in this market are Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Biopanda Reagents Ltd. (UK), Fassisi GmbH (Germany), Virbac (France), BioNote, Inc. (South Korea), SWISSAVANS AG (Switzerland), MEGACOR Diagnostik GmbH (Austria), and Woodley Equipment Company (UK).
The veterinary X-ray market is projected to reach USD 872 million by 2023, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).